vs
Side-by-side financial comparison of ESAB Corp (ESAB) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
ESAB Corp is the larger business by last-quarter revenue ($727.8M vs $617.8M, roughly 1.2× Hims & Hers Health, Inc.). ESAB Corp runs the higher net margin — 7.5% vs 3.3%, a 4.2% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 8.5%). ESAB Corp produced more free cash flow last quarter ($70.3M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 2.8%).
ESAB, Elektriska Svetsnings-Aktiebolaget, is an American-Swedish industrial company.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
ESAB vs HIMS — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $727.8M | $617.8M |
| Net Profit | $54.8M | $20.6M |
| Gross Margin | 37.0% | 71.9% |
| Operating Margin | 14.6% | 1.5% |
| Net Margin | 7.5% | 3.3% |
| Revenue YoY | 8.5% | 28.4% |
| Net Profit YoY | 2.1% | -20.8% |
| EPS (diluted) | $0.90 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $727.8M | $617.8M | ||
| Q3 25 | $715.6M | $599.0M | ||
| Q2 25 | $678.1M | $544.8M | ||
| Q1 25 | — | $586.0M | ||
| Q4 24 | $670.8M | $481.1M | ||
| Q3 24 | $673.3M | $401.6M | ||
| Q2 24 | $707.1M | $315.6M | ||
| Q1 24 | $689.7M | $278.2M |
| Q4 25 | $54.8M | $20.6M | ||
| Q3 25 | $66.9M | $15.8M | ||
| Q2 25 | $67.4M | $42.5M | ||
| Q1 25 | — | $49.5M | ||
| Q4 24 | $53.7M | $26.0M | ||
| Q3 24 | $68.2M | $75.6M | ||
| Q2 24 | $82.9M | $13.3M | ||
| Q1 24 | $60.0M | $11.1M |
| Q4 25 | 37.0% | 71.9% | ||
| Q3 25 | 37.2% | 73.8% | ||
| Q2 25 | 37.6% | 76.4% | ||
| Q1 25 | — | 73.5% | ||
| Q4 24 | 38.5% | 76.8% | ||
| Q3 24 | 37.7% | 79.2% | ||
| Q2 24 | 38.2% | 81.3% | ||
| Q1 24 | 37.0% | 82.4% |
| Q4 25 | 14.6% | 1.5% | ||
| Q3 25 | 15.2% | 2.0% | ||
| Q2 25 | 16.2% | 4.9% | ||
| Q1 25 | — | 9.9% | ||
| Q4 24 | 16.6% | 3.9% | ||
| Q3 24 | 15.7% | 5.6% | ||
| Q2 24 | 16.9% | 3.5% | ||
| Q1 24 | 16.0% | 3.6% |
| Q4 25 | 7.5% | 3.3% | ||
| Q3 25 | 9.3% | 2.6% | ||
| Q2 25 | 9.9% | 7.8% | ||
| Q1 25 | — | 8.4% | ||
| Q4 24 | 8.0% | 5.4% | ||
| Q3 24 | 10.1% | 18.8% | ||
| Q2 24 | 11.7% | 4.2% | ||
| Q1 24 | 8.7% | 4.0% |
| Q4 25 | $0.90 | $0.08 | ||
| Q3 25 | $1.09 | $0.06 | ||
| Q2 25 | $1.10 | $0.17 | ||
| Q1 25 | — | $0.20 | ||
| Q4 24 | $0.87 | $0.10 | ||
| Q3 24 | $1.11 | $0.32 | ||
| Q2 24 | $1.35 | $0.06 | ||
| Q1 24 | $0.98 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $218.2M | $228.6M |
| Total DebtLower is stronger | $1.3B | — |
| Stockholders' EquityBook value | $2.1B | $540.9M |
| Total Assets | $4.9B | $2.2B |
| Debt / EquityLower = less leverage | 0.63× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $218.2M | $228.6M | ||
| Q3 25 | $258.2M | $345.8M | ||
| Q2 25 | $291.3M | $1.1B | ||
| Q1 25 | — | $273.7M | ||
| Q4 24 | $249.4M | $220.6M | ||
| Q3 24 | $253.7M | $165.5M | ||
| Q2 24 | $228.5M | $129.3M | ||
| Q1 24 | $76.5M | $105.2M |
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $992.8M | — |
| Q4 25 | $2.1B | $540.9M | ||
| Q3 25 | $2.1B | $581.0M | ||
| Q2 25 | $1.9B | $562.7M | ||
| Q1 25 | — | $549.3M | ||
| Q4 24 | $1.8B | $476.7M | ||
| Q3 24 | $1.8B | $440.1M | ||
| Q2 24 | $1.7B | $362.0M | ||
| Q1 24 | $1.6B | $344.5M |
| Q4 25 | $4.9B | $2.2B | ||
| Q3 25 | $4.4B | $2.2B | ||
| Q2 25 | $4.2B | $1.9B | ||
| Q1 25 | — | $891.7M | ||
| Q4 24 | $4.0B | $707.5M | ||
| Q3 24 | $4.1B | $602.3M | ||
| Q2 24 | $4.0B | $480.5M | ||
| Q1 24 | $3.8B | $448.1M |
| Q4 25 | 0.63× | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.60× | — | ||
| Q3 24 | 0.59× | — | ||
| Q2 24 | 0.63× | — | ||
| Q1 24 | 0.61× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $81.5M | $61.3M |
| Free Cash FlowOCF − Capex | $70.3M | $-2.5M |
| FCF MarginFCF / Revenue | 9.7% | -0.4% |
| Capex IntensityCapex / Revenue | 1.5% | 10.3% |
| Cash ConversionOCF / Net Profit | 1.49× | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | $238.0M | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $81.5M | $61.3M | ||
| Q3 25 | $46.6M | $148.7M | ||
| Q2 25 | $35.4M | $-19.1M | ||
| Q1 25 | — | $109.1M | ||
| Q4 24 | $126.9M | $86.4M | ||
| Q3 24 | $101.0M | $85.3M | ||
| Q2 24 | $83.0M | $53.6M | ||
| Q1 24 | $44.5M | $25.8M |
| Q4 25 | $70.3M | $-2.5M | ||
| Q3 25 | $37.4M | $79.3M | ||
| Q2 25 | $28.1M | $-69.5M | ||
| Q1 25 | — | $50.1M | ||
| Q4 24 | $102.2M | $59.5M | ||
| Q3 24 | $90.4M | $79.4M | ||
| Q2 24 | $74.0M | $47.6M | ||
| Q1 24 | $37.1M | $11.8M |
| Q4 25 | 9.7% | -0.4% | ||
| Q3 25 | 5.2% | 13.2% | ||
| Q2 25 | 4.1% | -12.8% | ||
| Q1 25 | — | 8.5% | ||
| Q4 24 | 15.2% | 12.4% | ||
| Q3 24 | 13.4% | 19.8% | ||
| Q2 24 | 10.5% | 15.1% | ||
| Q1 24 | 5.4% | 4.3% |
| Q4 25 | 1.5% | 10.3% | ||
| Q3 25 | 1.3% | 11.6% | ||
| Q2 25 | 1.1% | 9.3% | ||
| Q1 25 | — | 10.1% | ||
| Q4 24 | 3.7% | 5.6% | ||
| Q3 24 | 1.6% | 1.5% | ||
| Q2 24 | 1.3% | 1.9% | ||
| Q1 24 | 1.1% | 5.0% |
| Q4 25 | 1.49× | 2.98× | ||
| Q3 25 | 0.70× | 9.43× | ||
| Q2 25 | 0.53× | -0.45× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | 2.36× | 3.32× | ||
| Q3 24 | 1.48× | 1.13× | ||
| Q2 24 | 1.00× | 4.03× | ||
| Q1 24 | 0.74× | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESAB
| Consumable Products | $477.9M | 66% |
| Equipment Products | $249.9M | 34% |
HIMS
Segment breakdown not available.
